CASS Pharmaceuticals
CASS Pharmaceuticals is dedicated to creating a future where effective and comprehensive treatment of diabetes is readily available and affordable. They focus on developing innovative insulin and glucagon programs to improve diabetes management, including rapid-acting insulin and bi-hormonal pumps. Their team includes experienced leaders and scientists committed to advancing diabetes care.
Industries
Nr. of Employees
small (1-50)
Products
Insulin development program
Program focused on development of rapid-acting insulin formulations and delivery approaches intended to improve absorption kinetics and postprandial glucose control.
Glucagon development program
Program aimed at developing glucagon formulations and approaches for use in combination with insulin delivery (bi-hormonal systems) to improve glycemic stability and enable pump-based glucagon dosing.
Insulin development program
Program focused on development of rapid-acting insulin formulations and delivery approaches intended to improve absorption kinetics and postprandial glucose control.
Glucagon development program
Program aimed at developing glucagon formulations and approaches for use in combination with insulin delivery (bi-hormonal systems) to improve glycemic stability and enable pump-based glucagon dosing.
Expertise Areas
- Diabetes therapeutics development
- Drug formulation and delivery
- Device integration with digital health
- Clinical trial management and execution
Key Technologies
- Rapid-acting insulin analog development
- Glucagon stabilization chemistry
- Bi-hormonal pump systems
- Inhalation drug delivery